A study assessing changes in LDL over time in people living with HIV (PLWH) following switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF)
Latest Information Update: 31 Jul 2020
At a glance
- Drugs Tenofovir alafenamide (Primary) ; Tenofovir disoproxil fumarate
- Indications HIV infections
- Focus Therapeutic Use
Most Recent Events
- 10 Jul 2020 Results assessing weight changes before and after switching in people living with HIV who switched from TDF to TAF presented at the 23rd International AIDS Conference
- 27 Jan 2020 New trial record